Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K

被引:15
作者
Barrett, DG
Catalano, JG
Deaton, DN [1 ]
Long, ST
Miller, LR
Tavares, FX
Wells-Knecht, KJ
Wright, LL
Zhou, HQQ
机构
[1] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Discovery Res Biol, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Dept Res Bioanal & Drug Metab, Res Triangle Pk, NC 27709 USA
[4] GlaxoSmithKline, Dept Mol Pharmacol, Res Triangle Pk, NC 27709 USA
[5] GlaxoSmithKline, Dept World Wide Phys Properties, Res Triangle Pk, NC 27709 USA
关键词
cathepsin K; ketoamide; cysteine protease inhibitors;
D O I
10.1016/j.bmcl.2004.02.085
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An orally available series of ketoamide-based inhibitors of cathepsin K has been identified. Starting from a potent inhibitor with poor oral bioavailability, modifications to P-1 and P-1' elements led to enhancements in solubility and permeability. These improvements resulted in orally available cathepsin K inhibitors. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2543 / 2546
页数:4
相关论文
共 24 条
[1]   Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors.: Use of L-mannaric acid as a peptidomimetic scaffold [J].
Alterman, M ;
Björsne, M ;
Mühlman, A ;
Classon, B ;
Kvarnström, I ;
Danielson, H ;
Markgren, PO ;
Nillroth, U ;
Unge, T ;
Hallberg, A ;
Samuelsson, B .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (20) :3782-3792
[2]   Intramolecular opening of β-lactams with amines as a strategy toward enzymatically or photochemically triggered activation of lactenediyne prodrugs [J].
Banfi, L ;
Guanti, G ;
Rasparini, M .
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2003, 2003 (07) :1319-1336
[3]   Design of small molecule ketoamide-based inhibitors of cathepsin K [J].
Catalano, JG ;
Deaton, DN ;
Long, ST ;
McFadyen, RB ;
Miller, LR ;
Payne, JA ;
Wells-Knecht, KJ ;
Wright, LL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) :719-722
[4]   Exploration of the P1SAR of aldehyde cathepsin K inhibitors [J].
Catalano, JG ;
Deaton, DN ;
Furfine, ES ;
Hassell, AM ;
McFadyen, RB ;
Miller, AB ;
Miller, LR ;
Shewchuk, LM ;
Willard, DH ;
Wright, LL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) :275-278
[5]  
CATALANO JG, 2003, Patent No. 03062192
[6]   Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones [J].
Conaway, HH ;
Grigorie, D ;
Lerner, UH .
JOURNAL OF ENDOCRINOLOGY, 1997, 155 (03) :513-521
[7]   A GENERAL-METHOD FOR THE SYNTHESIS OF TETRAMIC ACID-DERIVATIVES [J].
DESHONG, P ;
CIPOLLINA, JA ;
LOWMASTER, NK .
JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (07) :1356-1364
[8]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[9]  
Einhorn Thomas A., 1996, P3
[10]   CORTISOL MODULATION OF OSTEOBLAST METABOLIC-ACTIVITY IN CULTURED NEONATAL RAT BONE [J].
HAHN, TJ ;
WESTBROOK, SL ;
HALSTEAD, LR .
ENDOCRINOLOGY, 1984, 114 (05) :1864-1870